Loading Events

Upcoming Events › Online

Events Search and Views Navigation

Event Views Navigation

Notice: Utilizing the form controls will dynamically update the content

May 2019

  • Online

Five Points for the Community Clinician: Diagnosing and Managing Invasive Mold Infections

May 2, 2019 - May 2, 2020

PROGRAM OVERVIEW Invasive mold infections are a significant cause of morbidity and mortality due to the increasing population of immunocompromised patients and newly identified risk factors beyond malignancy and immunosuppression. Through real-world case studies and discussion, Dr Peter Pappas and Dr Stephen Threlkeld will address the key challenges faced by community-based and rural clinicians, including: shifting trends in the fungal landscape with a focus on Aspergillus spp. and Mucorales; recognizing and diagnosing these infections; and the importance of prompt, informed,…

Find out more »
  • Online

Genetic Testing for Inherited Retinal Diseases in Ophthalmology: What Do Clinicians Need to Know?

May 30, 2019 - May 30, 2020

PROGRAM OVERVIEW The landscape of genetic testing and treatment for inherited retinal diseases (IRDs) is rapidly evolving. Keeping up to date on clinical trials, ordering and interpreting genetic test results, and knowing how and when to best collaborate with genetic counselors can be a challenge for ophthalmologists, retina specialists, and optometrists. In this interactive activity, experts in retinal disease and genetic counseling discuss challenges and opportunities to enhance collaborative patient care, including 2 compelling IRD cases. TARGET AUDIENCE General ophthalmologists…

Find out more »
  • Online

The Pharmacist’s Role in Managing Disease-Modifying Therapies in Adults With Multiple Sclerosis

May 31, 2019 - May 31, 2020

Goal: To educate pharmacists about MS pathophysiology and the new American Academy of Neurology recommendations for the use of disease-modifying therapies (DMTs) in adults. Educational Objectives: Upon completion of this activity, participants should be better able to: DESCRIBE the pathophysiological mechanisms that contribute to multiple sclerosis (MS) EVALUATE the safety and efficacy of available disease-modifying therapies EMPLOY care coordination strategies that emphasize multidisciplinary collaboration and advocacy for individuals with MS DEFINE the pharmacist's role in providing drug management and administrative…

Find out more »
+ Export Events